Abstract
Ten ongoing studies designed to test the possibility that extracellular RNAs may serve as biomarkers in human disease are described. These studies, funded by the NIH Common Fund Extracellular RNA Communication Program, examine diverse extracellular body fluids, including plasma, serum, urine and cerebrospinal fluid. The disorders studied include hepatic and gastric cancer, cardiovascular disease, chronic kidney disease, neurodegenerative disease, brain tumours, intracranial haemorrhage,multiple sclerosis and placental disorders. Progress to date and the plans for future studies are outlined.
Original language | English |
---|---|
Article number | 27495 |
Journal | Journal of Extracellular Vesicles |
Volume | 4 |
Issue number | 1 |
DOIs | |
State | Published - 2015 |
Externally published | Yes |
Bibliographical note
Funding Information:We thank the NIH Common Fund for support these studies, via the NCATS UH2/UH3 Grants TR000931; TR000890; TR000921; TR000891; TR000906; TR000884; TR000903; TR000901; TR000923; TR000933. Also supported by NIA-AG08017. We also thank Dr. Thomas Tuschl and Dr. Manikkam Suthanthiran for feedback regarding this review. David Wong is co-founder of RNAmeTRIX Inc., a molecular diagnostic company. He holds equity in RNAmeTRIX, and serves as a company Director and Scientific Advisor. The University of California also holds equity in RNAme-TRIX. Intellectual property that David Wong invented and which was patented by the University of California has been licensed to RNAmeTRIX. All other authors have not received any funding or benefits from industry or elsewhere to conduct this study.
Publisher Copyright:
© 2015 Joseph F. Quinn et al.
Keywords
- Biomarkers
- ERCC
- ExRNA
- Extracellular RNA